On the 28th, an Indonesian Food and Drug Authority (BPOM) pharmaceutical delegation visited Daewoong Pharmaceutical’s Magok research center in Korea as part of its trip to attend the Global Bio‑Conference 2026.
The delegation examined Daewoong’s new‑drug and biopharmaceutical R&D system and infrastructure. Both parties discussed possible cooperation on product development, regulatory approval, and business expansion within Indonesia, as well as future clinical development and related regulatory matters.
規制動向2026年9月14日•3分で読めます
Indonesian BPOM delegation visits Daewoong Pharma’s Magok R&D center to explore collaboration
An Indonesian BPOM pharmaceutical delegation toured Daewoong Pharmaceutical’s Magok R&D facility, reviewing new‑drug and biopharma projects and discussing joint development and approval pathways in Indonesia.
Pharmacountryチームがまとめました · 出典: KPA News
トピック:
評価
(0)
(0)
(0)
(0)
(0)
評価を残す